With an improved understanding of the immune system, as well as the means by which it is manipulated by RABV infection, these novel, developing therapeutic options should focus on targeting the critical genes involved in immune evasion, such as the P protein, as well as looking to control the immune responses that stimulate viral propagation and infection. Here, OCA2 is linked to infection.